Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE

Area of Science:

• Immunology
• Neuroscience
• Endocrinology

Background:

• Interleukin-10 (IL-10) knockout (KO) mice show protection from experimental autoimmune encephalomyelitis (EAE) with low-dose estrogen (E2) treatment, similar to wild-type (WT) mice.
• Previous studies linked E2 treatment to decreased tumor necrosis factor, contributing to observed protection.

Purpose of the Study:

• To investigate the regulatory mechanisms by which E2 protects IL-10 KO mice from EAE.
• To understand alternative compensatory pathways for EAE protection in the absence of IL-10.

Main Methods:

• IL-10 KO and WT mice were treated with E2 or sham pellets before EAE induction.
• Mice were monitored for 21 days post-immunization, with spleen, lymph nodes, and brain analyzed by flow cytometry.
• Spinal cords were assessed using cytokine/chemokine arrays, RT-PCR, and histology.

Main Results:

• E2 treatment increased programmed death-ligands 1 and 2 on monocytes/macrophages in IL-10 KO mice.
• E2 increased CD73 in the inflamed CNS, enhancing anti-inflammatory adenosine production.
• E2 decreased splenic CD4+CD25+FoxP3+ regulatory T cells, downregulating pro-inflammatory genes in the spinal cord.

Conclusions:

• E2 stimulates previously unrecognized compensatory mechanisms for EAE protection in IL-10 KO mice.
• These E2-induced pathways provide disease protection comparable to IL-10-dependent effects in WT mice.